External validation of urinary C–C motif chemokine ligand 14 (CCL14) for prediction of persistent acute kidney injury

Background Persistent acute kidney injury (AKI) portends worse clinical outcomes and remains a therapeutic challenge for clinicians. A recent study found that urinary C–C motif chemokine ligand 14 (CCL14) can predict the development of persistent AKI. We aimed to externally validate urinary CCL14 fo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Critical care (London, England) Jg. 25; H. 1; S. 1 - 8
Hauptverfasser:	Bagshaw, Sean M., Al-Khafaji, Ali, Artigas, Antonio, Davison, Danielle, Haase, Michael, Lissauer, Matthew, Zacharowski, Kai, Chawla, Lakhmir S., Kwan, Thomas, Kampf, J. Patrick, McPherson, Paul, Kellum, John A.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	London BioMed Central 31.05.2021 BioMed Central Ltd Springer Nature B.V BMC
Schlagworte:	Acute kidney injury Acute renal failure Biological markers Biomarkers Chemokines Creatinine Critical care Critical Care Medicine Critically ill Diabetes Emergency Medicine Enrollments Health aspects Intensive Kidney diseases Ligands Medical examination Medicine Medicine & Public Health Mortality Patients Prediction Renal replacement therapy Risk factors Urine Validation Canada Validation Renal replacement therapy Acute kidney injury Mortality Prediction
ISSN:	1364-8535, 1466-609X, 1364-8535, 1366-609X, 1466-609X
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!